Goblet Cells on Gastric Biopsy: Gastric Intestinal Metaplasia
The presence of goblet cells on gastric biopsy indicates gastric intestinal metaplasia (GIM), a premalignant condition that requires H. pylori testing and eradication, but routine endoscopic surveillance is not recommended for most patients. 1
What Goblet Cells Mean
Goblet cells are not normally present in gastric epithelium—their appearance represents intestinal metaplasia, where the normal gastric columnar epithelium has been replaced by intestinal-type epithelium. This is a recognized precancerous condition that increases gastric cancer risk 2, 3.
Immediate Management Steps
1. Test and Treat H. pylori (Strong Recommendation)
All patients with GIM must be tested for H. pylori and treated if positive. This is the only strong recommendation in GIM management, supported by moderate-quality evidence 1. H. pylori eradication serves as primary and secondary prevention for gastric cancer 4.
2. Risk Stratification
Assess whether your patient has high-risk features that warrant consideration of surveillance:
GIM-specific high-risk features:
- Incomplete (vs complete) intestinal metaplasia on pathology
- Extensive (vs limited) GIM involving both antrum and body
- Family history of gastric cancer in first-degree relative
Patient-level high-risk features:
- Racial/ethnic minorities (Asian, Hispanic, Black Americans)
- Immigrants from high gastric cancer incidence regions
- Age ≥45 years with multiple behavioral risk factors (smoking, high-salt diet)
Surveillance Decision-Making
For Most Patients: No Routine Surveillance
The AGA suggests against routine endoscopic surveillance for incidentally detected GIM (conditional recommendation, very low-quality evidence) 1. This applies to patients without high-risk features who were not undergoing targeted gastric cancer screening.
For High-Risk Patients: Shared Decision-Making
Patients with high-risk features may reasonably elect for surveillance if they:
- Place high value on potential (but uncertain) gastric cancer mortality reduction
- Place low value on risks of repeated endoscopies
- Understand the evidence is limited
If surveillance is chosen:
- Consider repeat endoscopy within 1 year for complete risk stratification in very high-risk patients
- For ongoing surveillance, consider repeat endoscopy every 3-5 years with high-quality technique 1
High-Quality Endoscopy Requirements
When performing surveillance endoscopy, use 4:
- High-definition white-light endoscopy with image enhancement
- Gastric mucosal cleansing and adequate insufflation
- Systematic biopsy protocol (antrum and body)
- Adequate inspection time and photodocumentation
Common Pitfalls to Avoid
Don't confuse GIM with Barrett's esophagus: Goblet cells at the gastroesophageal junction with concurrent gastric changes (H. pylori gastritis, gastric intestinal metaplasia) likely represent gastric intestinal metaplasia extending proximally, not Barrett's 5
Don't skip H. pylori testing: This is the only intervention with strong evidence for risk reduction—failure to test and treat is a missed opportunity for cancer prevention
Don't automatically commit to surveillance: The evidence for surveillance benefit is very weak; most patients do not require it 1
Beware of "blue cells": Some cells may mimic goblet cells on Alcian blue staining but lack true intestinal differentiation. PAS staining has higher sensitivity and specificity for true goblet cells 6
Evidence Quality Context
The surveillance recommendations are conditional with very low-quality evidence, meaning substantial uncertainty exists. The strong recommendation for H. pylori eradication is based on moderate-quality evidence showing gastric cancer risk reduction. Asian countries with population-based endoscopic screening have demonstrated 42% reduction in gastric cancer mortality, but these data may not directly translate to sporadic GIM detection in Western populations 4.
The 2025 AGA Clinical Practice Update reinforces that endoscopy remains the best screening modality for high-risk individuals, with emphasis on high-quality technique and appropriate patient selection 4.